Abstract
In our effort directed toward the discovery of new anti-diabetic agent for the treatment of diabetes, a library of biscoumarin derivative 1-18 was synthesized and evaluated for α-glucosidase inhibitory potential. All eighteen (18) compounds displayed assorted α-glucosidase activity with IC50 values 16.5-385.9 μM, if compared with the standard acarbose (IC50 = 906 ± 6.387 μM). In addition, molecular docking studies were carried out to explore the binding interactions of biscoumarin derivatives with the enzyme. This study has identified a new class of potent α-glucosidase inhibitors.
| Original language | English |
|---|---|
| Pages (from-to) | 245-252 |
| Number of pages | 8 |
| Journal | European Journal of Medicinal Chemistry |
| Volume | 81 |
| DOIs | |
| State | Published - 23 Jun 2014 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Biscoumarin
- Molecular docking
- α-Glucosidase inhibition
ASJC Scopus subject areas
- Pharmacology
- Drug Discovery
- Organic Chemistry
Fingerprint
Dive into the research topics of 'Synthesis and molecular docking studies of potent α-glucosidase inhibitors based on biscoumarin skeleton'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver